Search

Kunbin Qu

from Los Altos, CA
Age ~55
Get Report
Also known as:
Kumbin Qu, Kunbin Kunbin Qu
Related to:
Albert K Xiao, 21Patrick L Xiao, 28Qianhua Qu, 87Kunbin U QKunhong Qu, 58Xiao Zheng, 60
Connected to:
Cathy Qu, 35Cindy P Qu, 28Daniel A Qu, 33Feng Qu, 61Howard H Qu, 56Jenny Qu, 29Jinyue Qu, 63Qiuping Qu, 61Sherry X Qu, 58Tony F Qu, 42

Kunbin Qu Phones & Addresses

  • Los Altos, CA
  • San Jose, CA
  • Tracy, CA
  • 1584 Walnut Dr, Palo Alto, CA 94303 (650) 473-9377
  • 3100 Vicente St, San Francisco, CA 94116
  • Foster City, CA
  • Santa Clara, CA
  • Albany, NY
  • Sacramento, CA
  • 1584 Walnut Dr, Palo Alto, CA 94303

Work

Position: Professional/Technical

Education

Degree: High school graduate or higher

Business Records

Name / Title
Company / Classification
Phones & Addresses
Kunbin Qu
Principal
Qq Consult
Business Consulting Services
1584 Walnut Dr, Palo Alto, CA 94303

Publications

Us Patents

Identification Of Pharmacophores From Co-Crystals Of Spleen Tyrosine Kinase (Syk) And Syk Ligands

View page
US Patent:
7962290, Jun 14, 2011
Filed:
Jan 9, 2007
Appl. No.:
11/651363
Inventors:
Kunbin Qu - Palo Alto CA, US
Assignee:
Rigel Pharmaceuticals, Inc. - South San Francisco CA
International Classification:
G01N 33/48
G01N 31/00
G01N 33/53
G06G 7/58
US Classification:
702 19, 702 27, 703 11, 435 771
Abstract:
The invention comprises for methods of identifying pharmacophores based on the spleen tyrosine kinase (SYK) protein or fragment thereof. The invention further provides methods of identifying SYK inhibitors using pharmacophores that are identified from co-crystals of SYK and its ligands. Further, the invention comprises methods of inhibiting SYK comprising contacting the residues lining the binding site with an inhibitor compound identified from pharmacophores.

Multidimensional Biodata Integration And Relationship Inference

View page
US Patent:
20040162852, Aug 19, 2004
Filed:
Dec 11, 2003
Appl. No.:
10/480567
Inventors:
Kunbin Qu - Foster City CA, US
Nan Lin - Foster City CA, US
Yanmei Lu - Foster City CA, US
Donald Payan - Hillsborough CA, US
International Classification:
G06F007/00
US Classification:
707/104100
Abstract:
This invention provides an advanced platform for the analysis of biological data that emphasizes pathway mapping and relationship inference based upon data acquired from multiple diverse sources (). The platform employs a bioinformatic system () that integrates data from the diverse sources (), connecting related genes and proteins and inferring biological functions () in the context of global cellular processes.

Method Of Predicting Breast Cancer Prognosis

View page
US Patent:
20200263257, Aug 20, 2020
Filed:
Feb 7, 2020
Appl. No.:
16/784696
Inventors:
- Redwood City CA, US
Dominick SINICROPI - Woodside CA, US
Robert J. PELHAM - Belmont CA, US
Michael R. CRAGER - Menlo Park CA, US
Francois COLLIN - Berkeley CA, US
James C. STEPHANS - DECEASED, US
Mei-Lan LIU - San Mateo CA, US
John D. MORLAN - Hayward CA, US
Kunbin QU - Palo Alto CA, US
Assignee:
GENOMIC HEALTH, INC. - Redwood City CA
International Classification:
C12Q 1/6886
G01N 33/574
C12Q 1/686
G16B 20/00
Abstract:
The present invention relates to biomarkers associated with breast cancer prognosis. These biomarkers include coding transcripts and their expression products, as well as non-coding transcripts, and are useful for predicting the likelihood of breast cancer recurrence in a breast cancer patient. The present invention also relates to a novel method of identifying intergenic sequences that correlate with a clinical outcome.

Method Of Predicting Breast Cancer Prognosis

View page
US Patent:
20190256923, Aug 22, 2019
Filed:
Jan 17, 2019
Appl. No.:
16/250179
Inventors:
- Redwood City CA, US
Dominick SINICROPI - Woodside CA, US
Robert J. PELHAM - Belmont CA, US
Michael R. CRAGER - Menlo Park CA, US
Francois COLLIN - Berkeley CA, US
James C. STEPHANS - Redwood City CA, US
Mei-Lan LIU - San Mateo CA, US
John D. MORLAN - Hayward CA, US
Kunbin QU - Palo Alto CA, US
Assignee:
GENOMIC HEALTH, INC. - Redwood City CA
International Classification:
C12Q 1/6886
G16B 20/00
C12Q 1/686
G01N 33/574
Abstract:
The present invention relates to biomarkers associated with breast cancer prognosis. These biomarkers include coding transcripts and their expression products, as well as non-coding transcripts, and are useful for predicting the likelihood of breast cancer recurrence in a breast cancer patient. The present invention also relates to a novel method of identifying intergenic sequences that correlate with a clinical outcome.

Method Of Predicting Breast Cancer Prognosis

View page
US Patent:
20160222463, Aug 4, 2016
Filed:
Jan 29, 2016
Appl. No.:
15/011206
Inventors:
- Redwood City CA, US
Dominick S. SINICROPI - Woodside CA, US
Robert J. PELHAM - Belmont CA, US
Michael R. CRAGER - Menlo Park CA, US
Francois COLLIN - Berkeley CA, US
James C. STEPHANS - Redwood City CA, US
Mei-Lan LIU - San Mateo CA, US
John D. MORLAN - Hayward CA, US
Kunbin QU - Palo Alto CA, US
Assignee:
GENOMIC HEALTH, INC. - Redwood City CA
International Classification:
C12Q 1/68
Abstract:
The present invention relates to biomarkers associated with breast cancer prognosis. These biomarkers include coding transcripts and their expression products, as well as non-coding transcripts, and are useful for predicting the likelihood of breast cancer recurrence in a breast cancer patient, The present invention also relates to a novel method of identifying intergenic sequences that correlate with a clinical outcome.

Gene Fusions And Alternatively Spliced Junctions Associated With Breast Cancer

View page
US Patent:
20150302143, Oct 22, 2015
Filed:
Nov 4, 2013
Appl. No.:
14/440582
Inventors:
- Redwood City CA, US
Kunbin Qu - Palo Alto CA, US
Mei-Lan Liu - San Mateo CA, US
Ranjana Ambannavar - Newark CA, US
James Stephans - Redwood City CA, US
John Pan - Los Angeles CA, US
Assignee:
GENOMIC HEALTH, INC. - Redwood City CA
International Classification:
G06F 19/18
G06F 19/22
G06F 19/00
C12Q 1/68
Abstract:
The present invention relates to gene fusions and alternative spliced junctions associated with breast cancer. The present invention also relates to novel methods of identifying gene fusions and alternative spliced junctions in RNA sequencing data. The present invention further relates to predicting prognosis of a breast cancer patient based on the number of gene fusion events.

Method Of Predicting Breast Cancer Prognosis

View page
US Patent:
20140296085, Oct 2, 2014
Filed:
Nov 2, 2012
Appl. No.:
14/355642
Inventors:
- Redwood City CA, US
Dominick S. Sinicropi - Woodside CA, US
Robert J. Pelham - Belmont CA, US
Michael R. Crager - Menlo Park CA, US
Francois Collin - Berkeley CA, US
James C. Stephans - Redwood City CA, US
Mei-Lan Liu - San Mateo CA, US
John D. Morlan - Foster City CA, US
Kunbin Qu - Palo Alto CA, US
Assignee:
GENOMIC HEALTH, INC. - Redwood City CA
International Classification:
G06F 19/18
C12Q 1/68
US Classification:
506 8, 435 612, 702 19
Abstract:
The present invention relates to biomarkers associated with breast cancer prognosis. These biomarkers include coding transcripts and their expression products, as well as non-coding transcripts, and are useful for predicting the likelihood of breast cancer recurrence in a breast cancer patient, The present invention also relates to a novel method of identifying intergenic sequences that correlate with a clinical outcome.
Control profile
Kunbin Qu from Los Altos, CA, age ~55 Get Report